Loading...
Market
Which major pharmaceutical company will be the next to settle with Baltimore over the opioid crisis by end of 2024?
2
Resolution / Starting Odds
Johnson & Johnson • 25%
McKesson • 25%
Cardinal Health • 25%
Other • 25%
Official announcements from the City of Baltimore or court records
Story
Baltimore Settles with Teva, Walgreens for $160 Million in Opioid Crisis, Totaling $402.5 Million
Sep 10, 2024, 08:37 PM
The City of Baltimore has reached settlements with Teva Pharmaceuticals and Walgreens, totaling $160 million, for their roles in the city's opioid crisis. The settlement with Teva amounts to $80 million, while the settlement with Walgreens also amounts to $80 million. These settlements, announced on Monday and Tuesday, are part of a larger effort by Baltimore to address the opioid crisis, with the city securing a total of $402.5 million from various drug companies. The settlements come ahead of a trial scheduled to begin next week against the three remaining defendants in the litigation.
View original story
Similar markets
McKesson • 25%
AmerisourceBergen • 25%
Johnson & Johnson • 25%
Other • 25%
Yes • 50%
No • 50%
McKesson • 25%
Cardinal Health • 25%
AmerisourceBergen • 25%
Other • 25%
Johnson & Johnson • 25%
Teva Pharmaceuticals • 25%
Endo International • 25%
Other • 25%
Chicago • 25%
Los Angeles • 25%
Houston • 25%
Other • 25%
Walmart • 25%
CVS • 25%
Walgreens • 25%
Other • 25%
Walmart • 25%
CVS • 25%
Walgreens • 25%
Other • 25%
Yes • 50%
No • 50%
Settlement • 25%
Trial verdict • 25%
Dismissal • 25%
Other • 25%